Harold R. Zimmer - Net Worth and Insider Trading

Harold R. Zimmer Net Worth

The estimated net worth of Harold R. Zimmer is at least $414,640 dollars as of 2025-05-09. Harold R. Zimmer is the Director of Knight Therapeutics Inc and owns about 73,000 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $414,640. Details can be seen in Harold R. Zimmer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Harold R. Zimmer has not made any transactions after 2019-08-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Harold R. Zimmer

Harold R. Zimmer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Harold R. Zimmer owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .

Click here to see the complete history of Harold R. Zimmer’s form 4 insider trades.

Insider Ownership Summary of Harold R. Zimmer

Ticker	Company	Transaction Date	Type of Owner
TSX:GUD	Knight Therapeutics Inc	2019-08-07	Director

Harold R. Zimmer Latest Holdings Summary

Harold R. Zimmer currently owns a total of 1 stock. Harold R. Zimmer owns 73,000 shares of Knight Therapeutics Inc (TSX:GUD) as of August 7, 2019, with a value of $414,640.

Latest Holdings of Harold R. Zimmer

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TSX:GUD	Knight Therapeutics Inc	2019-08-07	73,000	5.68	414,640

Holding Weightings of Harold R. Zimmer

Harold R. Zimmer Form 4 Trading Tracker

According to the SEC Form 4 filings, Harold R. Zimmer has made a total of 0 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years. The most-recent trade in Knight Therapeutics Inc is the acquisition of 1,000 shares on August 7, 2019, which cost Harold R. Zimmer around $7,380.

Insider Trading History of Harold R. Zimmer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Harold R. Zimmer Trading Performance

GuruFocus tracks the stock performance after each of Harold R. Zimmer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Harold R. Zimmer is 13.19%. GuruFocus also compares Harold R. Zimmer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Harold R. Zimmer within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Harold R. Zimmer's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Harold R. Zimmer

Average Return

Average return per transaction

Outperforming Transactions

0 out of 3 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	3.91
Relative Return to S&P 500(%)	6.63

Harold R. Zimmer Ownership Network

Ownership Network List of Harold R. Zimmer

No Data

Ownership Network Relation of Harold R. Zimmer

Harold R. Zimmer Owned Company Details

What does Knight Therapeutics Inc do?

Who are the key executives at Knight Therapeutics Inc?

Harold R. Zimmer is the Director of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include 10% Security Holder Sime Armoyan , Director & Senior Officer Samira Sakhia , and Senior Officer Amal Khouri .

Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary

Over the past 18 months, Harold R. Zimmer made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net sale of 4,168,100 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .

In summary, during the past 3 months, insiders sold 4,729,100 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 17,600 shares, with a net sale of 4,711,500 shares. During the past 18 months, 5,043,300 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 790,200 shares were bought by its insiders, resulting in a net sale of 4,253,100 shares.

Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Knight Therapeutics Inc Insider Transactions

No Available Data

Harold R. Zimmer Mailing Address

Above is the net worth, insider trading, and ownership report for Harold R. Zimmer. Currently GuruFocus does not have mailing address information for Harold R. Zimmer.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.